Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q9IA96

Entry ID Method Resolution Chain Position Source
AF-Q9IA96-F1 Predicted AlphaFoldDB

No variants for Q9IA96

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q9IA96

No associated diseases with Q9IA96

4 regional properties for Q9IA96

Type Name Position InterPro Accession
domain Netrin domain 169 - 292 IPR001134
domain Netrin module, non-TIMP type 183 - 286 IPR018933
domain Frizzled domain 32 - 154 IPR020067
domain SFRP2, cysteine-rich domain 33 - 160 IPR041764

Functions

Description
EC Number
Subcellular Localization
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

1 GO annotations of molecular function

Name Definition
Wnt-protein binding Binding to a Wnt-protein, a secreted growth factor involved in signaling.

4 GO annotations of biological process

Name Definition
apoptotic process A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
canonical Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
cell differentiation The process in which relatively unspecialized cells, e.g. embryonic or regenerative cells, acquire specialized structural and/or functional features that characterize the cells, tissues, or organs of the mature organism or some other relatively stable phase of the organism's life history. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
negative regulation of canonical Wnt signaling pathway Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.

24 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O19116 SFRP1 Secreted frizzled-related protein 1 Bos taurus (Bovine) PR
O57328 FZD1 Frizzled-1 Gallus gallus (Chicken) PR
Q9DEQ4 SFRP1 Secreted frizzled-related protein 1 Gallus gallus (Chicken) PR
Q863H1 SFRP2 Secreted frizzled-related protein 2 Canis lupus familiaris (Dog) (Canis familiaris) PR
Q8N474 SFRP1 Secreted frizzled-related protein 1 Homo sapiens (Human) PR
Q9ULW2 FZD10 Frizzled-10 Homo sapiens (Human) PR
O75084 FZD7 Frizzled-7 Homo sapiens (Human) PR
Q9UP38 FZD1 Frizzled-1 Homo sapiens (Human) PR
Q14332 FZD2 Frizzled-2 Homo sapiens (Human) PR
O00144 FZD9 Frizzled-9 Homo sapiens (Human) PR
O60353 FZD6 Frizzled-6 Homo sapiens (Human) PR
Q6FHJ7 SFRP4 Secreted frizzled-related protein 4 Homo sapiens (Human) PR
Q96HF1 SFRP2 Secreted frizzled-related protein 2 Homo sapiens (Human) PR
Q9Z1N6 Sfrp4 Secreted frizzled-related sequence protein 4 Mus musculus (Mouse) PR
Q8C4U3 Sfrp1 Secreted frizzled-related protein 1 Mus musculus (Mouse) PR
O70421 Fzd1 Frizzled-1 Mus musculus (Mouse) PR
Q9JIP6 Fzd2 Frizzled-2 Mus musculus (Mouse) PR
Q61090 Fzd7 Frizzled-7 Mus musculus (Mouse) PR
P97299 Sfrp2 Secreted frizzled-related protein 2 Mus musculus (Mouse) PR
Q08463 Fzd1 Frizzled-1 Rattus norvegicus (Rat) PR
Q9JLS4 Sfrp4 Secreted frizzled-related protein 4 Rattus norvegicus (Rat) PR
Q08464 Fzd2 Frizzled-2 Rattus norvegicus (Rat) PR
Q7YRN1 SFRP4 Secreted frizzled-related protein 4 Macaca mulatta (Rhesus macaque) PR
Q5BL72 fzd7 Frizzled-7 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MPRRLCALLL LASQCLGSTA GLFPFGEPDF SYKRSNCKPI PAPMLLCRGI EYQSMRLPNL
70 80 90 100 110 120
LGHETVQEVL EQATTWIPLV QKQCHPDTRK FLCSLFAPVC IDDLDEIIQP CHSLCEEVKE
130 140 150 160 170 180
SCAPVMSAFG FPWPDMLDCS RFPKDNDLCI PLASSDHILP VTREAPKVCD ACKNKNEDDN
190 200 210 220 230 240
DIMENLCKND FALKIKVKEI AYINGDTKIT PETKSKTIYK LNGLTERDLR KIVLWLKGGL
250 260 270 280 290
QCTCDEMNDI NVPYLVMGQK QAGELVITSL KRWQKGQRAF KRFSRSIRKL QC